Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ambev Q1 Adj $0.05 Beats $0.04 Estimate, Sales $4.10B Beat $3.85B Estimate

Author: Benzinga Newsdesk | May 08, 2024 09:20am
Ambev (NYSE:ABEV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.10 billion which beat the analyst consensus estimate of $3.85 billion by 6.39 percent. This is a 3.64 percent increase over sales of $3.95 billion the same period last year.

Posted In: ABEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist